Roble Belko & Company’s Sanofi SNY Stock Holding History

Roble Belko & Company’s Portfolio SNY Stock Details SNY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	–	Sell	-575	Closed	-$24K	–	316
2016 Q2	$24K	Hold	575	–	–	0.01%	144
2016 Q1	$23K	Buy	+575	New	+$23.1K	0.01%	132

Other funds holding SNY

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $33B AUM 40.62% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Hotchkis & Wiley Capital Management Los Angeles, California $34.3B AUM 22.63% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return

Roble Belko & Company's SNY Position: Q3 2016 in Review

Roble Belko & Company sold out of Sanofi (SNY) in Q3 2016, closing a stake of 575 shares — an estimated $24K sold.

Roble Belko & Company first reported a position in SNY in Q1 2016 and held it in 2 quarters. The position peaked at $24K in Q2 2016. 450 funds tracked by Wall St. Rank hold SNY as of Q3 2016.

Roble Belko & Company reported no remaining Sanofi position as of Q3 2016 after selling out during the quarter.
Roble Belko & Company sold 575 Sanofi shares in Q3 2016, an estimated $24K.
Roble Belko & Company first reported a position in Sanofi in Q1 2016 and held it in 2 quarters.
Roble Belko & Company's Sanofi position peaked at $24K in Q2 2016.
450 funds tracked by Wall St. Rank held Sanofi as of Q3 2016.

Based on Roble Belko & Company's 13F filing for Q3 2016, filed 1 Nov 2016.